{"filings":[{"id":1305356,"accession_number":"0001628280-26-045801","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2026-06-26T20:42:18+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Fortrea appoints Jason Knoblauch as CFO effective July 6, 2026; Jill McConnell steps down","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Jason Knoblauch appointed CFO effective July 6, 2026, succeeding Jill McConnell who steps down but remains for transition.","Knoblauch brings over 20 years of life sciences finance experience; previously CFO at Clario and Curia.","Compensation: $570k salary, 85% target bonus, $1.25M cash inducement, RSUs $2.3M, PSUs $1.7M.","FY2026 guidance reiterated: revenue $2,550M-$2,650M, adjusted EBITDA $190M-$220M.","McConnell's departure not due to any disagreement on financial reporting, internal controls, or auditing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":1027196,"accession_number":"0001628280-26-042827","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2026-06-12T20:04:27+00:00","items":["5.07"],"status":"ready","headline":"Fortrea Holdings Stockholders Elect Directors, Ratify Auditor, and Approve Executive Compensation at Annual Meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Anshul Thakral (75,014,537 for), Peter M. Neupert (70,709,138 for), and William J. Sharbaugh (74,923,196 for) elected to the Board.","Appointment of Deloitte & Touche LLP as independent auditor for FY2026 ratified with 86,104,449 votes for.","Advisory (non-binding) vote on named executive officer compensation approved with 73,544,293 votes for.","A quorum of 86,194,966 shares was present at the June 9, 2026 Annual Meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.15,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":96972,"accession_number":"0001628280-26-030101","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea Q1 revenue $636.5M; adjusted EPS $0.16 beats prior year; book-to-bill 1.15x","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $636.5M, down 2.3% YoY from $651.3M; GAAP net loss $23.6M ($0.25 loss per share).","Adjusted net income $15.2M, adjusted diluted EPS $0.16 vs. $0.02 in Q1 2025.","Adjusted EBITDA $47.0M, up 55% from $30.3M; backlog $7.85B; book-to-bill 1.15x (3rd straight quarter >1.1x).","Full-year 2026 guidance affirmed: revenue $2.55B-$2.65B, adjusted EBITDA $190M-$220M.","CEO cites strong commercial traction and investment in new Fortrea Intelligent Technology platform."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.25,"consensus_revenue_estimate":null,"consensus_revenue_actual":636500000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":111363,"accession_number":"0001628280-26-011942","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2026-02-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea Q4 rev $660.5M, adj EBITDA $54M; FY adj net income $40.4M; guides 2026 rev $2.55-2.65B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 revenue $660.5M vs $697.0M YoY; GAAP net loss $(32.5)M ($(0.35)/share) vs $(73.9)M loss in Q4 2024.","Full-year GAAP net loss $(986.2)M ($(10.81)/share) includes $797.9M non-cash goodwill impairment; adjusted net income $40.4M ($0.43/share) vs $30.1M in 2024.","Full-year adjusted EBITDA $189.9M vs $202.5M in 2024; Q4 adjusted EBITDA $54.0M vs $56.0M.","Book-to-bill Q4 1.14x, trailing twelve months 1.02x; backlog $7,728M.","2026 guidance: revenue $2.55B-$2.65B, adjusted EBITDA $190M-$220M."],"consensus_eps_estimate":null,"consensus_eps_actual":-10.81,"consensus_revenue_estimate":null,"consensus_revenue_actual":2723400000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127974,"accession_number":"0001628280-25-053390","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-11-20T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Fortrea completes $75.7M tender offer for 7.500% Senior Secured Notes due 2030","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Tender offer expired Nov 18, 2025; accepted $75,743,000 aggregate principal amount of notes.","Final proration factor of 0.154199 applied due to oversubscription above the $75,744,000 maximum.","Notes carry 7.500% coupon, due 2030; purchase reduces outstanding debt and future interest expense.","Company tendered for cash; no new debt issuance or refinancing disclosed.","Jill McConnell, CFO, signed the report on Nov 20, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":127973,"accession_number":"0001628280-25-049217","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-11-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea Q3 revenue $701.3M, GAAP net loss $(0.17)/share; raises FY revenue guide","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $701.3M (+4% YoY); GAAP net loss $(15.9)M vs $(18.5)M loss in Q3 2024.","Adjusted EPS $0.12 vs $0.23 a year ago; adjusted EBITDA $50.7M vs $64.2M.","Book-to-bill 1.13x for Q3; backlog $7,644M; trailing 12-month book-to-bill 1.07x.","FY 2025 revenue guidance raised to $2,700-2,750M; adjusted EBITDA narrowed to $175-195M.","Cost saving initiatives on track; recent CEO transition noted as smooth."],"consensus_eps_estimate":null,"consensus_eps_actual":-10.53,"consensus_revenue_estimate":null,"consensus_revenue_actual":2062900000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144755,"accession_number":"0001628280-25-042341","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-09-22T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Fortrea appoints William Sharbaugh as Class III director effective Sept 22, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["William Sharbaugh appointed to Fortrea Board as Class III director, effective Sept 22, 2025.","Sharbaugh served as COO of PPD, Inc. from 2007-2021 and held roles at Bristol-Myers Squibb and Merck.","No committee assignments yet; will receive standard non-employee director compensation per existing policy.","Sharbaugh currently chairs Ora LLC and serves on boards of Launch Therapeutics, Alcami, and BioCare."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144754,"accession_number":"0001965040-25-000088","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-08-27T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Fortrea amends inducement plan, adds 2.2M shares for new hire awards","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Board increased shares reserved under 2025 Inducement Award Plan by 2,200,000 shares.","Plan originally established solely for Anshul Thakral; now open for other new hires.","Awards limited to new employees (or after bona fide non-employment) under Nasdaq Listing Rule 5635(c)(4).","Full text of amended plan will be filed with Q3 2025 Form 10-Q."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":144753,"accession_number":"0001965040-25-000048","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-08-06T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea Q2 GAAP loss $374.9M on $309.1M goodwill impairment; raises 2025 revenue guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $710.3M, +7% YoY; GAAP net loss $374.9M ($4.14 diluted loss) includes $309.1M non-cash goodwill impairment.","Adjusted net income $17.6M ($0.19 adjusted diluted EPS) vs adjusted net loss $2.3M in Q2 2024.","Book-to-bill 0.79x for quarter, backlog $7,547M; trailing 12-month book-to-bill 1.10x.","Raising FY2025 revenue guidance to $2,600-2,700M; affirming adjusted EBITDA guidance $170-200M.","New CEO Anshul Thakral joined Aug 4, succeeding interim CEO Peter Neupert who remains chairman."],"consensus_eps_estimate":null,"consensus_eps_actual":-10.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":1361600000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163155,"accession_number":"0001965040-25-000036","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-06-12T23:59:59+00:00","items":["5.02","5.07"],"status":"ready","headline":"Fortrea shareholders approve amended incentive plan with 6.5M share increase","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders at June 10 annual meeting approved A&R 2023 Omnibus Incentive Plan, adding 6.5M shares to pool.","Plan amendments include minimum vesting, no dividend payment until vesting, and eliminated liberal share recycling.","All three director nominees elected: Amrit Ray, Erin L. Russell, Machelle Sanders (each with > 60M votes for).","Ratification of Deloitte & Touche as auditor for FY2025 approved (82.7M for, 0.1M against).","Advisory vote on named executive officer compensation passed with 68.1M for vs. 3.3M against."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163154,"accession_number":"0001193125-25-139600","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-06-12T23:59:59+00:00","items":["1.01","3.03","5.03","8.01","9.01"],"status":"ready","headline":"Fortrea adopts limited-duration rights plan with 10% trigger and 50% discount","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Rights trigger if any person acquires 10%+ of common stock; other holders can buy shares at 50% discount.","Plan expires June 10, 2026; board may redeem rights at $0.001 per right.","Adopted in response to stock price dislocation and recent third-party interest to capitalize on it.","Record date for rights distribution is June 23, 2025; rights initially trade with common stock."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163153,"accession_number":"0001193125-25-139161","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-06-11T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Fortrea names Anshul Thakral as permanent CEO effective August 4, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Anshul Thakral appointed President and CEO, effective August 4, 2025; replaces interim CEO Peter Neupert who remains chairman.","Thakral has over 20 years experience in CRO, pharma, and biotech; Co-founder/CEO of Launch Therapeutics since 2022.","Offer letter includes $1.1M base salary, 150% target bonus, and inducement equity grants of ~$12.5M (RSUs+PSAs) tied to performance.","Thakral also appointed Class III director; his term expires at 2026 annual meeting.","Severance plan amended to include CEO; equity grants outside 2023 Omnibus Incentive Plan (Nasdaq inducement exception)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163150,"accession_number":"0001193125-25-120888","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K/A","filed_at":"2025-05-15T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Fortrea appoints Erin Russell to Audit Committee effective May 13, 2025","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Board appointed Erin Russell to Audit Committee on May 9, 2025, effective May 13, 2025.","Russell was elected to the Board on March 7, 2025; committee assignment now disclosed.","No other changes from the original 8-K filed March 10, 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163152,"accession_number":"0001965040-25-000023","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea Q1 revenue $651M, GAAP loss $562.9M; CEO Pike steps down, interim CEO named","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["GAAP net loss $562.9M ($6.25 diluted loss) includes $488.8M goodwill impairment.","Adjusted EPS $0.02; adjusted EBITDA $30.3M, up from $27.1M YoY.","Revenue $651.3M (down 1.6% YoY); backlog $7,721M; book-to-bill 1.02x.","Reiterates FY2025 guidance: revenue $2.45-$2.55B, adj EBITDA $170-$200M.","CEO Thomas Pike stepping down May 13; Lead Independent Director Peter Neupert named Interim CEO."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":163151,"accession_number":"0001965040-25-000022","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-05-12T23:59:59+00:00","items":["5.02","7.01","8.01","9.01"],"status":"ready","headline":"Fortrea CEO Thomas Pike steps down; Peter Neupert appointed interim CEO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Thomas Pike steps down on May 13, 2025; will serve as special consultant through at least Sept 30, 2025.","Lead Independent Director Peter M. Neupert appointed Interim CEO and Board Chair, effective May 13, 2025.","Board changes: Neupert resigns as Lead Independent Director and from Audit and Nominating committees; Amrit Ray becomes Lead Independent Director.","Executive search for a permanent CEO is at an advanced stage; Pike's departure not due to any disagreement.","Pike receives severance per his employment agreement; consulting agreement allows RSU vesting to continue."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":181071,"accession_number":"0001193125-25-051088","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-03-10T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Fortrea appoints Erin L. Russell as Class II director, effective March 7, 2025","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Appointment follows agreement with Starboard Value LP dated February 21, 2025.","Ms. Russell brings finance and healthcare experience; not yet assigned to any board committee.","Will receive compensation under Fortrea's non-employee director policy.","No arrangements with other persons or family relations with officers/directors."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":181070,"accession_number":"0001965040-25-000008","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-03-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea reports Q4 revenue $697M, full-year net loss $271.5M; issues 2025 guidance below 2024","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2024 revenue $697.0M (-1.8% YoY); GAAP net loss $(73.9)M, diluted EPS $(0.82) vs loss $(48.6)M in Q4 2023.","Full-year 2024 revenue $2,696.4M (-5.1% vs 2023); GAAP net loss $(271.5)M vs $(31.7)M; adjusted EBITDA $202.5M vs $245.8M.","Q4 book-to-bill 1.35x; backlog $7,699M; cash $118.5M, gross debt $1,142.0M.","Entered covenant amendment on Feb 28, 2025 for flexibility through Q4 2026.","FY2025 guidance: revenue $2,450M-$2,550M, adjusted EBITDA $170M-$200M (down YoY)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":181069,"accession_number":"0001193125-25-032114","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2025-02-21T23:59:59+00:00","items":["1.01","5.02","7.01","9.01"],"status":"ready","headline":"Fortrea appoints Erin Russell to board, reaches cooperation pact with Starboard","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Erin L. Russell appointed independent director; effective before next board meeting.","Starboard, holding ~5.4% of FTRE, agreed to standstill, voting commitments.","Andrew Eckert resigned due to change in occupation; 7,282 RSUs accelerated vesting.","Peter Neupert appointed Lead Independent Director.","Starboard can appoint an additional director after August 2025 if ownership threshold met."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":197949,"accession_number":"0001965040-24-000060","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2024-11-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea Q3 revenue $674.9M, GAAP loss $(0.21)/share; FY rev guidance lowered to $2.7B-$2.725B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 2024 revenue $674.9M, down from $713.8M YoY; GAAP net loss $(18.5)M vs $(16.1)M YoY.","Adjusted EBITDA $64.2M, down from $68.2M YoY but up 16.3% sequentially.","GAAP diluted EPS $(0.21); adjusted diluted EPS $0.23.","Book-to-bill ratio 1.23x for Q3; backlog increased to $7.57B.","FY 2024 revenue guidance updated to $2.70B-$2.725B; adjusted EBITDA guidance unchanged at $220M-$240M."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.99,"consensus_revenue_estimate":null,"consensus_revenue_actual":1999400000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214114,"accession_number":"0001193125-24-207183","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K/A","filed_at":"2024-08-26T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Fortrea appoints director Sanders to two board committees effective Aug 22","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board member Machelle Sanders was elected effective May 14, 2024.","Appointed to Management Development and Compensation Committee effective August 22, 2024.","Also appointed to Nominating, Corporate Governance and Compliance Committee effective same date.","No other amendments to the original 8-K filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214116,"accession_number":"0001965040-24-000050","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2024-08-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea Q2 revenue down 8.6% to $662.4M, net loss $99.3M, cuts full-year guidance","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $662.4M (-8.6% YoY); GAAP net loss $99.3M vs net income $25.0M prior year.","Adjusted EBITDA $55.2M vs $71.9M YoY; adjusted loss per share $(0.03).","Book-to-bill 0.96x for Q2; backlog $7.37B; trailing-12-month book-to-bill 1.16x.","Paid down $504M debt using divestiture proceeds from Endpoint Clinical and Patient Access.","Revised FY2024 guidance: revenue $2.70-2.75B, adjusted EBITDA $220-240M, down from prior."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.69,"consensus_revenue_estimate":null,"consensus_revenue_actual":1324500000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":214115,"accession_number":"0001193125-24-177519","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2024-07-11T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"Fortrea appoints Robert Parks as Chief Accounting Officer, effective August 2024","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Robert Parks appointed CAO, starting August 2024; succeeds Amanda Warren.","Parks previously CAO at SailPoint, Syneos, and IQVIA; CPA with 30 years experience.","Amanda Warren will remain principal accounting officer until August, then advisor through November.","Parks will report to CFO Jill McConnell and serve on Finance Leadership Team."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233342,"accession_number":"0001965040-24-000047","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2024-06-20T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Fortrea repays $275M in term loans, plans $200M more via $300M receivables securitization","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Repaid $129M on June 14 and $146M on June 18, total $275M principal reduction on term loans.","On June 20, Fortrea Receivables LLC sold receivables, received $300M under securitization program.","Intends to apply up to $200M of securitization proceeds to further reduce term loans before Q2 end.","Estimated debt as of June 30, 2024: $1,142M ($570M senior notes + $572M term loans).","Company intends to fully utilize the $300M receivables securitization program for the foreseeable future."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233335,"accession_number":"0001965040-24-000044","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K/A","filed_at":"2024-06-07T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Fortrea amends 8-K to correct non-GAAP data in TTM March 2024 corporate presentation","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Corrected administrative errors in non-GAAP information on slides 8 and 10 of May 24 corporate presentation.","Updated presentation furnished as Exhibit 99.1 on June 7, 2024; no changes to 10-K or 10-Q.","Trailing twelve months ended March 31, 2024 data revised; no other changes to original presentation."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233341,"accession_number":"0001965040-24-000041","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2024-06-04T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Fortrea completes divestiture of Endpoint Clinical and Patient Access to Arsenal for $295M plus $45M milestone","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Final purchase price $295M paid at closing plus $45M upon achieving transition milestones.","Net proceeds to be used to reduce a portion of Fortrea's overall debt.","Sam Osman appointed CEO of the new entities; Ray Hill named chairman.","Fortrea becomes a pure-play clinical CRO after the divestiture."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233340,"accession_number":"0001965040-24-000039","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2024-05-24T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Fortrea makes updated corporate presentation available; no specific data provided in filing","summary_kind":"llm","event_type":"other_material","confidence":"low","bullets":["Filing under Item 7.01 with an updated corporate presentation, but exhibit text is truncated and lacks financial figures.","Presentation available on company's IR website; no earnings, guidance, or operational metrics disclosed in the 8-K body.","No material new information can be extracted from the provided exhibit content."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233339,"accession_number":"0001965040-24-000024","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2024-05-16T23:59:59+00:00","items":["5.02","5.07","7.01","9.01"],"status":"ready","headline":"Fortrea appoints Machelle Sanders to Board of Directors; effective May 14","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Machelle Sanders appointed to Fortrea’s Board as a Class II director, effective May 14, 2024, with term until 2025 annual meeting.","Sanders is North Carolina Secretary of Commerce and brings over 30 years of pharmaceutical and biotechnology operational experience.","She previously held quality assurance and manufacturing roles at Biogen, Purdue Pharma, and AkzoNobel, and serves on BioCryst board."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.35,"calibrated_materiality_score":0.35,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233338,"accession_number":"0001965040-24-000019","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2024-05-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea reports Q1 revenue $662.1M, net loss $81.6M; FY revenue guidance $2.785-2.855B","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 revenue $662.1M vs $693.9M YoY; GAAP net loss $81.6M vs net income $7.3M YoY.","Adjusted EBITDA $29.5M vs $41.7M YoY; GAAP diluted EPS $(0.91), adjusted $(0.04).","Book-to-bill 1.11x; backlog $7.4B; free cash flow $(34.9)M.","Planned divestiture of Endpoint Clinical and Patient Access to Arsenal Capital on track for Q2 close.","FY 2024 guidance: revenue $2,785-2,855M, adjusted EBITDA $240-260M."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.13,"consensus_revenue_estimate":null,"consensus_revenue_actual":662100000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233337,"accession_number":"0001965040-24-000017","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["1.01","2.03","7.01"],"status":"ready","headline":"Fortrea enters $300M receivables facility, amends credit covenants to ease leverage through mid-2025","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$300M receivables securitization with PNC Bank; 3-year term ending May 2027.","Credit amendment raises max total leverage ratio to 6.00x for Q2/Q3 2024, stepping down to 5.30x by Q3 2025.","Minimum interest coverage ratio lowered to 1.70x for Q2/Q3 2024, returning to 2.00x by Q3 2025.","Paid consent fees; limited investments and restricted payments; divestiture proceeds must repay debt.","Terminated existing $80M ARPP (no outstanding borrowings)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":233336,"accession_number":"0001965040-24-000014","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2024-04-01T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Fortrea board member Betty Larson resigns; 6,354 RSUs accelerated","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Betty Larson resigned from the Board effective March 30, 2024, due to a change in principal occupation.","Resignation was not due to any disagreement with the Company on operations, policies, or practices.","Accelerated vesting of 6,354 RSUs that would have vested on July 18, 2024.","Company initiated a search to fill the board vacancy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251450,"accession_number":"0001965040-24-000006","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2024-03-11T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Fortrea reports FY2023 net loss; sells Endpoint & Patient Access to Arsenal for $345M","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["FY2023 revenue $3,109M (+0.4% YoY); GAAP net loss $(3.4)M vs $192.9M income in 2022; adjusted EBITDA $267.3M, down from $405.1M.","Q4 2023 revenue $775.4M; GAAP net loss $(36.0)M; adjusted EBITDA $67.2M; book-to-bill 1.30x.","2024 guidance: revenue $3,140M-$3,205M; adjusted EBITDA $280M-$320M, excluding planned divestiture impact.","Divests Endpoint Clinical and Fortrea Patient Access to Arsenal for $345M ($295M at close + $50M milestones); expected close Q2 2024.","Sam Osman to become CEO of divested businesses; remaining Fortrea becomes pure-play CRO focused on Phase 1-4."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":251449,"accession_number":"0001965040-24-000002","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2024-01-08T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Fortrea reports Q4 book-to-bill >1.2x; exits 40% of TSAs; review clears trial conduct","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Book-to-bill ratio exceeded 1.2x for Q4 2023 and for first six months as an independent company.","Exited approximately 40% of Transition Services Agreements with former parent by end of 2023.","Hired a recognized AI industry expert to lead machine learning efforts.","Independent expert review found no deficit in Fortrea's conduct on two ACELYRIN clinical trials.","Select new business proposals and awards were affected by news surrounding the clinical trials."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":268988,"accession_number":"0001965040-23-000048","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2023-11-29T23:59:59+00:00","items":["7.01"],"status":"ready","headline":"Fortrea disputes ACELYRIN claims on HS and PsA trial conduct; stands by data integrity","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Fortrea objects to ACELYRIN's implication that its conduct of the Hidradenitis Suppurativa trial impacted outcomes.","Disputes accuracy of statements about testing processes and who uncovered the third-party programming error in Psoriatic Arthritis trial.","Sequencing issue isolated to two arms of the PsA trial, unrelated to the HS trial; no patient safety risk per ACELYRIN.","Third-party programmer not endpoint Clinical (affiliated with Fortrea); cannot be named due to contractual commitments."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":268987,"accession_number":"0001965040-23-000046","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2023-11-21T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Fortrea sets May 14, 2024 for first annual meeting as public company","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["2024 Annual Meeting scheduled for Tuesday, May 14, 2024.","Rule 14a-8 stockholder proposals must be received by December 31, 2023.","Other stockholder proposals (including director nominations) due Jan 15 – Feb 14, 2024.","Meeting will be the company's first annual meeting as a public company.","Proposals and nominations to be sent to Corporate Secretary at Durham, NC address."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":268986,"accession_number":"0001965040-23-000039","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2023-11-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea Q3 revenue up 2% to $776M but GAAP net loss of $13.1M; adjusted EBITDA down 33% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["GAAP diluted EPS of ($0.15) vs $0.68 in Q3 2022; adjusted EPS of $0.24.","Clinical Services revenue $711.7M, Enabling Services $64.7M; book-to-bill 1.24x.","Backlog $7.13B; cash and cash equivalents $107.5M, gross debt $1.63B.","FY2023 revenue guidance $3,075M-$3,130M; reaffirms adjusted EBITDA $255M-$285M.","First quarter as independent company; CEO cites positive customer response and transformation progress."],"consensus_eps_estimate":null,"consensus_eps_actual":0.37,"consensus_revenue_estimate":null,"consensus_revenue_actual":2333600000.0,"consensus_period":"2023-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":286068,"accession_number":"0001965040-23-000035","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K/A","filed_at":"2023-08-24T23:59:59+00:00","items":["2.02","7.01","9.01"],"status":"ready","headline":"Fortrea corrects trailing 12-month Adjusted EBITDA to $344.5M from $378.9M due to tax provision error","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Administrative error in Original Earnings Release: 'Provision for income taxes' line item was $70.6M (should be $36.2M).","Corrected Trailing 12 Adjusted EBITDA is $344.5M, down from originally reported $378.9M (overstated by $34.4M).","No other changes to Q2 2023 results: revenue $793M, GAAP net income $28.3M, EPS $0.32, adjusted EBITDA $72.5M.","Full-year 2023 guidance unchanged: revenue $3,034M–$3,096M, adjusted EBITDA $255M–$285M."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":286071,"accession_number":"0001965040-23-000032","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2023-08-21T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Fortrea grants CEO Thomas Pike $20M equity award; mix changed to 50/50 RSUs and options","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Grant date fair value of $20M: 377,074 RSUs plus options on 799,272 shares at $26.52.","Board changed award mix from 30% RSUs/70% options (per employment agreement) to 50% RSUs/50% options.","Awards vest in three equal installments over 3 years (first anniversary, second anniversary, Jan 9, 2026).","Initial Equity Grant satisfies Section 4(b)(iii) of the CEO's employment agreement with Labcorp assigned at spinoff.","RSU award agreement (Ex-10.1) and option agreement (Ex-10.2) filed as exhibits."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":286070,"accession_number":"0001965040-23-000027","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2023-08-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Fortrea Q2 net income drops to $28.3M from $66.4M; revenue flat, adjusted EBITDA down 37% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Revenue $793.0M flat YoY; Clinical Services $726.1M, Enabling Services $66.9M.","GAAP net income $28.3M ($0.32 EPS) vs $66.4M ($0.75 EPS) in Q2 2022.","Adjusted EBITDA $72.5M vs $115.3M YoY, down ~37%.","Full-year 2023 guidance: revenue $3,034M-$3,096M, adj. EBITDA $255M-$285M.","Completed spin-off from parent at end of June, now independent CRO."],"consensus_eps_estimate":null,"consensus_eps_actual":0.51,"consensus_revenue_estimate":null,"consensus_revenue_actual":1557200000.0,"consensus_period":"2023-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":286069,"accession_number":"0001965040-23-000021","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2023-07-03T23:59:59+00:00","items":["1.01","2.03","5.01","5.02","5.03","8.01","9.01"],"status":"ready","headline":"Fortrea Holdings completes spinoff from Labcorp; issues $570M 7.5% notes due 2030","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Spinoff effective June 30, 2023; Labcorp stockholders receive one Fortrea share per Labcorp share held on June 20 record date.","Issued $570M 7.5% Senior Secured Notes due 2030; entered $450M revolver, $500M Term A, $570M Term B credit facilities.","Board appointed with three classes; Thomas Pike (CEO), Jill McConnell (CFO) confirmed; Sandra van der Vaart and Glenn Eisenberg resigned.","Transition Services Agreement with Labcorp for up to 24 months; Tax Matters Agreement restricts certain actions for two years post-spinoff.","Adopted 2023 Omnibus Incentive Plan and Employee Stock Purchase Plan; non-employee directors get $67,500 annual cash retainer and $210K RSU grant."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305941,"accession_number":"0001965040-23-000015","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2023-06-30T23:59:59+00:00","items":["1.01","2.03","7.01","9.01"],"status":"ready","headline":"Fortrea issues $570M notes and enters $1.52B credit facilities to fund spin-off from Labcorp","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Issued $570M 7.500% Senior Secured Notes due 2030 at par; proceeds escrowed pending spin-off completion by Sept 30, 2023.","Entered $1.52B Senior Secured Credit Facilities: $450M revolver, $500M Term A loan, $570M Term B loan; SOFR+1.50%-3.75% spreads.","Initial borrowings of ~$1.64B (notes + term loans) to fund $1.635B special dividend to Labcorp and transaction fees.","Established $80M accounts receivable purchase program; sold $17.5M of receivables on June 28, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305940,"accession_number":"0001965040-23-000008","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2023-06-21T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Fortrea appoints David Smith to Board as Audit Committee chair","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Board size increased from two to three; David Smith appointed effective June 15, 2023.","Smith will serve as chair of the Audit Committee.","He is former EVP and CFO of Charles River Laboratories, retired May 2022.","Compensation per standard director program described in Fortrea's Form 10."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":305939,"accession_number":"0001965040-23-000005","cik":1965040,"company_name":"Fortrea Holdings Inc.","ticker":"FTRE","form_type":"8-K","filed_at":"2023-06-12T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Fortrea prices $570M senior secured notes at 7.5% due 2030 for spinoff funding","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["$570M senior secured notes priced at 7.500% interest, maturing July 1, 2030.","Proceeds to fund portion of $1.605B cash distribution to Labcorp and transaction fees.","Notes held in escrow; spinoff closing required, else mandatory redemption by Sept 30, 2023.","Closing expected June 27, 2023 subject to customary conditions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1425621985.4016395,"market_cap_bucket":"not_microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}